Masaki Iino

11PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersCardiovascular medicine and haematology not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 28, 2026
A Survey Study of Patient-Physician Communication and Treatment Decision-Making Preference at Treatment Initiation and After Disease Stabilization in Newly Diagnosed Multiple Myeloma.

|May 20, 2025
A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia.

Hiroki Yamaguchi, Masaki Iino, Shugo Kowata

|Mar 01, 2024
ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone.

Yasunori Kogure, Hiroshi Handa, Yuta Ito

|Feb 29, 2024
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study).

Yu Abe, Shiro Kubonishi, Masaki Ri

|Mar 21, 2022
Real-world experience of treatment with thrombopoietin receptor agonists in anti-thymocyte globulin-naïve patients with aplastic anemia: an observational retrospective analysis in a single institution.

Masaki Iino, Atsushi Jinguji, Tomoya Sato

|Sep 26, 2020
Consolidation with 90 Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma.

Katsuhiro Miura, Hideki Tsujimura, Yasufumi Masaki

Pageof 2

Frequent Collaborators

2 joint publications

Tomoki Ito

2 joint publications

Motoaki Shiratsuchi

2 joint publications

Kenji Yokoyama

2 joint publications

Yoshiaki Tomiyama